secwatch.observer — SEC 8-K summary
======================================

Issuer:     Purple Innovation, Inc. (PRPL)
CIK:        0001643953
Form:       8-K
Filed at:   2023-04-13T23:59:59+00:00
Accession:  0001213900-23-029560
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Purple settles proxy fight with Coliseum; board adds 3 new directors, redeems preferred stock, ends poison pill
--------------------------------------------------------------------------------

- Board expands to 8; Paul Zepf and Pano Anthos resign; Adam Gray becomes Chair; Gary DiCamillo remains Lead Independent Director.
- Coliseum nominees Hoby Darling, Carter Pate, and Erika Serow join board; Scott Peterson added to slate for 2023 annual meeting.
- Purple will redeem Proportional Representation Preferred Linked Stock and terminate September 2022 stockholder rights agreement (poison pill).
- Coliseum drops litigation, agrees to standstill through 2024 annual meeting and not to exceed 44.7% ownership, subject to exceptions.
- Company to reimburse Coliseum up to $4M in legal fees; 2023 annual meeting to be held by June 16, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1643953/000121390023029560/0001213900-23-029560-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1643953/000121390023029560/ea176891-8k_purple.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-029560

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer